Uni-Bio Science Group Ltd
HKEX:690

Watchlist Manager
Uni-Bio Science Group Ltd Logo
Uni-Bio Science Group Ltd
HKEX:690
Watchlist
Price: 0.112 HKD -0.88% Market Closed
Market Cap: 668.8m HKD

Gross Margin
Uni-Bio Science Group Ltd

82.2%
Current
80%
Average
63.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
82.2%
=
Gross Profit
484.6m
/
Revenue
589.6m

Gross Margin Across Competitors

No Stocks Found

Uni-Bio Science Group Ltd
Glance View

Market Cap
668.8m HKD
Industry
Biotechnology

Uni-Bio Science Group Ltd. is an investment holding company with interests in pharmaceutical research and development. The company employs 326 full-time employees The company went IPO on 2001-11-12. The firm operates through four segments. In-house Chemical Pharmaceutical Products segment is engaged in the manufacture and sales of in-house chemical pharmaceutical products. Its chemical pharmaceutical products include Pinapu, among others. In-house Biological Pharmaceutical Products segment is engaged in the manufacture and sales of in-house biological pharmaceutical products. Its biological pharmaceutical products include GeneTime and GeneSoft, among others. In-house Biological Pipeline segment is engaged in the industrialization of in-house biological pipeline. Its biological pipeline products include Uni-E4 and Uni-PTH, among others. Third-party Pharmaceutical Products segment is engaged in the sales of third-party pharmaceutical products.

Intrinsic Value
0.182 HKD
Undervaluation 39%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
82.2%
=
Gross Profit
484.6m
/
Revenue
589.6m
What is the Gross Margin of Uni-Bio Science Group Ltd?

Based on Uni-Bio Science Group Ltd's most recent financial statements, the company has Gross Margin of 82.2%.

Back to Top